Correlation Between Ruentex Development and Foresee Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Ruentex Development and Foresee Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ruentex Development and Foresee Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ruentex Development Co and Foresee Pharmaceuticals Co, you can compare the effects of market volatilities on Ruentex Development and Foresee Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ruentex Development with a short position of Foresee Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ruentex Development and Foresee Pharmaceuticals.

Diversification Opportunities for Ruentex Development and Foresee Pharmaceuticals

-0.22

Correlation Coefficient

Ruentex Development  Foresee Pharmaceuticals

Very good diversification

The 3 months correlation between Ruentex and Foresee is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Ruentex Development Co and Foresee Pharmaceuticals Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Foresee Pharmaceuticals and Ruentex Development is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ruentex Development Co are associated (or correlated) with Foresee Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Foresee Pharmaceuticals has no effect on the direction of Ruentex Development i.e., Ruentex Development and Foresee Pharmaceuticals go up and down completely randomly.

Pair Corralation between Ruentex Development and Foresee Pharmaceuticals

Assuming the 90 days trading horizon Ruentex Development Co is expected to under-perform the Foresee Pharmaceuticals. In addition to that, Ruentex Development is 1.12 times more volatile than Foresee Pharmaceuticals Co. It trades about -0.13 of its total potential returns per unit of risk. Foresee Pharmaceuticals Co is currently generating about 0.16 per unit of volatility. If you would invest  7,760  in Foresee Pharmaceuticals Co on December 4, 2024 and sell it today you would earn a total of  740.00  from holding Foresee Pharmaceuticals Co or generate 9.54% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Ruentex Development Co  vs.  Foresee Pharmaceuticals Co

Ruentex Development

Risk-Adjusted Performance

Very Weak

Over the last 90 days Ruentex Development Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Foresee Pharmaceuticals

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Foresee Pharmaceuticals Co are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Foresee Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Ruentex Development and Foresee Pharmaceuticals

The main advantage of trading using opposite Ruentex Development and Foresee Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ruentex Development position performs unexpectedly, Foresee Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Foresee Pharmaceuticals will offset losses from the drop in Foresee Pharmaceuticals' long position.

The idea behind Ruentex Development Co and Foresee Pharmaceuticals Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.